NORTHEAST PHARMACEUTICAL GROUP CO., LTD.

Northeast Pharmaceutical Group Co., Ltd.

000597

CNE0000009G0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
5.01 ^CNY	-1.18%		+5.47%	-6.36%

May. 06	Northeast Pharmaceutical's Unit Gets Nod to Produce Azithromycin for Injection	MT
Apr. 25	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Northeast Pharmaceutical Group Co., Ltd. Approves the Profit Distribution for 2021

April 22, 2022 at 03:32 pm EDT

Northeast Pharmaceutical Group Co., Ltd. at the AGM held on April 21, 2022, approved the profit distribution for 2021 as cash dividend/10 shares (tax included): CNY 0.14000000.

Latest news about Northeast Pharmaceutical Group Co., Ltd.

Northeast Pharmaceutical's Unit Gets Nod to Produce Azithromycin for Injection	May. 06	MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023	Apr. 01	CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Northeast Pharmaceutical's Levocarnitine Gets Nod to Enter EU Market	Jan. 30	MT
Northeast Pharmaceutical's Piracetam Passes Generic Drug Evaluation in China	Nov. 01	MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Northeast Pharmaceutical to Set Up Joint Venture With Muscat Changming Investments in Oman	23-09-20	MT
Northeast Pharmaceutical Group Co., Ltd.(XSEC:000597) added to S&P Global BMI Index	23-09-18	CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Northeast Pharmaceutical Group Co., Ltd. Announces 2022 Final Cash Profit Distribution Plan, Payable on 16 May 2023	23-05-09	CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Northeast Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend for 2022	23-04-21	CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for 2022	23-03-30	CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Northeast Pharma Appoints Former Bank Auditor as CFO	23-02-09	MT
Northeast Pharmaceutical Unit Registers Anti-Seizure Drug in China	22-11-24	MT
Northeast Pharmaceutical’s Piracetam Tablets Gets Regulatory Approval	22-11-10	MT
Northeast Pharmaceutical Gets Supplementary Drug Application Approval For Tinidazole Tablets	22-11-01	MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Northeast Pharmaceutical's Levonorgestrel Gets Passing Evaluation	22-09-26	MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Dividend for the Year 2021, Payable on 27 May 2022	22-05-20	CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Northeast Pharmaceutical Group Co., Ltd. Approves the Profit Distribution for 2021	22-04-22	CI

Chart Northeast Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Northeast Pharmaceutical Group Co., Ltd.

More charts

Northeast Pharmaceutical Group Co., Ltd. specializes in the production and marketing of pharmaceutical ingredients and preparations. The group's products include antibiotics, vitamins, cardiovascular treatments, anesthetics, medical plants, etc. China accounts for 86.3% of net sales.

Sector

Pharmaceuticals

Calendar

2024-05-14 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.	-6.36%	991M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals